The Role of Inflammatory Parameters and Antibody Seroconversion on COVID-19 Outcomes in Patients with Central Obesity.
In COVID-19 patients with central obesity, we confirmed the association between higher pro- and anti-inflammatory parameters, and lower SARS-CoV-2 antibody with poor outcomes of COVID-19.
Authors
- Dante Saksono Harbuwono (ORCID: https://orcid.org/0000-0002-6006-2719)
- Dicky L. Tahapary (ORCID: https://orcid.org/0000-0002-4048-5159)
- Ketut Suastika (ORCID: https://orcid.org/0000-0001-7895-382X)
- Kuntjoro Harimurti (ORCID: https://orcid.org/0000-0002-9771-803X)
- Cleopas Martin Rumende (ORCID: https://orcid.org/0000-0002-7305-7337)
- Rona Kartika (ORCID: https://orcid.org/0000-0003-2818-4553)
- Evy Yunihastuti (ORCID: https://orcid.org/0000-0001-6650-0559)
- Tika Pradnjaparamita
- Farid Kurniawan (ORCID: https://orcid.org/0000-0002-0265-9883)
- Heri Wibowo
- Syahidatul Wafa
Institutions
- University of Indonesia (ID)
- Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (ID)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00